Stereotactic ablative radiotherapy achieves better overall survival than surgery for early lung cancer
Wednesday, May 13, 2015 - 21:30
in Health & Medicine
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care – invasive surgery – according to research from a phase III randomized international study.